Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech - Technical Analysis -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (467)	7/13/2002 10:52:58 AM
From: XenaLives	Read Replies (1) \| Respond to of 544

I admit that you know much more about the science than I. I don't have the training or the time to evaluate the science directly so my judgement is based on the quality of personnel and the charts. While the price has dropped horribly on this stock it seems to be under agressive accumulation at this time, and I am expecting a buyout. I will be the first to admit I could be totally wrong on this. When you speak of the drug benefit, are you talking about Neotrofin in Alzheimers, or the confusing results of the Parkinsons? They also have a drug going into pIII for cancer. I am wondering if the Alzheimers trial wasn't doomed from the beginning because of diagnostic problems with the disease itself and our limited knowledge of what is going on. Thanks for your input.